複数のがん診断検査: 世界市場の展望

Report Highlights

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Summary:

This report aims to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for multi-cancer diagnostic tests. Important trends are identified, and sales forecasts by product type categories and end user markets are provided through 2028; these are based on industry sources and considered assessments of the regulatory environment, healthcare policies, demographics and other factors that directly affect the market.

This report provides a complete review and analysis of the current multi-cancer diagnostic (MCD) test market and industry growth drivers and challenges. The emerging technologies in the market are thoroughly covered. The report identifies key companies and their product and pipeline portfolio. Recent developments in the market are covered.

Reasons for Doing This Study:

Cancer is one of the leading causes of mortality globally. The currently available methods to detect cancer are based on invasive procedures and can detect only a single cancer type. Cancers that are detected at late stages in patients have poor prognosis and may not be curable. Hence, there is a growing need for screening cancers at an early stage to improve treatment outcomes. The MCD test market helps with early detection of various cancers based on biomarkers such as circulating cell-free DNA (cfDNA).

This report will provide a detailed analysis of key factors governing the growth of the MCD test industry, providing strategic insights and recommendations for those seeking to expand their markets.

This study also provides detailed information regarding recent market developments and upcoming technologies. Market sizing and forecasting will shed light on the high-growth areas throughout the forecast period.

Report Scope:

The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented into laboratory-developed tests and in-vitro diagnostic tests based on test type. The market is segmented into diagnostic laboratories, hospitals and research institutions based on end user. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products. The study does not include single cancer early detection tests and detection tests for targeted therapies.

The regional markets covered are U.S., Europe and emerging markets.

Revenues are broken down by region, type and end user. For market estimates, data has been provided for 2020 and 2021 as historic years, 2022 as the base year, 2023 and a forecast for 2028.

Report Synopsis

Report Includes:

• An overview of the global market for the multi-cancer diagnostic tests
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Highlights of the current and future market potential of multi-cancer detection tests along with a detailed analysis of the drivers and challenges in the market
• Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by test type, end-user, and region
• Overview of the significant driving trends and challenges that affect the global market and its vendor landscape
• Discussion of sustainability trends and ESG developments in the multi-cancer diagnostic tests market, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed
• Information pertaining to the recent developments and upcoming technologies in the market
• An analysis of the market competitive landscape featuring the company revenue share analyses, recent mergers and acquisition activities, and venture funding outlook
• Company profiles of the major global players

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of the Report
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market and Technology Background
Introduction
Types of Biomarkers
Future Outlook
Chapter 4 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Unmet Needs in Cancer Screening
Government Measures for Cancer Screening
Market Restraints
Risk of False Positives or False Negatives
Regulatory and Reimbursement Uncertainty
Chapter 5 Market Breakdown by Test Type
Global Multi-Cancer Diagnostic Test Market, by Test Type
Market Size and Forecast
Laboratory Developed Tests
In-Vitro Diagnostic Tests
Chapter 6 Market Breakdown by End User
Global Multi-Cancer Diagnostic Test Market, by End User
Hospitals
Diagnostic Laboratories
Research Institutions
Chapter 7 Market Breakdown by Region
Global Multi-Cancer Diagnostic Test Market, by Region
The U.S.
Europe
Emerging Markets
Chapter 8 Emerging Technologies
Introduction
Identification of Tissue of Origin
Fragmentomics and Tumor-Educated Platelets
Liquid Biopsy with Imaging Data Analysis
Chapter 9 Competitive Landscape
Porter’s Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Degree of Competition
Recent Developments in the Multi-Cancer Diagnostic Market
Clinical Trial Activities
Chapter 10 Company Profiles
ANCHORDX MEDICAL CO. LTD.
BURNING ROCK BIOTECH LTD.
DELFI DIAGNOSTICS
EXACT SCIENCES CORP.
FREENOME HOLDINGS INC.
GENECAST INC.
GRAIL INC.
GUARDANT HEALTH INC.

List of Tables
Summary Table A : Global Multi-Cancer Diagnostic Test Market, Through 2028
Summary Table B : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 1 : Cancer Screening Guidelines
Table 2 : Global Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 3 : Global Multi-Cancer Diagnostic Test Market, by Laboratory Developed Tests Type, by Region, Through 2028
Table 4 : Global Multi-Cancer Diagnostic Test Market, by In-Vitro Diagnostic Test Type, by Region, Through 2028
Table 5 : Global Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 6 : Global Multi-Cancer Diagnostic Test Market Used in Hospitals, by Region, Through 2028
Table 7 : Global Multi-Cancer Diagnostic Test Market Used in Diagnostic Laboratories, by Region, Through 2028
Table 8 : Global Multi-Cancer Diagnostic Test Market Used in Research Institutions, by Region, Through 2028
Table 9 : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 10 : The U.S. Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 11 : The U.S. Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 12 : European Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 13 : European Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 14 : Emerging Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 15 : Emerging Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 16 : Emerging Multi-Cancer Diagnostic Test Market, by Country, Through 2028
Table 17 : Porter’s Five Force Analysis of the Multi-Cancer Diagnostic Test Market
Table 18 : Recent Developments in Multi-Cancer Diagnostics, 2022 and 2023
Table 19 : Ongoing Clinical Trials for Multi-Cancer Diagnostic Tests
Table 20 : MCD Technologies of Competitor Products
Table 21 : AnchorDx Medical Co. Ltd.: Company Snapshot
Table 22 : Burning Rock Biotech Ltd.: Company Snapshot
Table 23 : Delfi Diagnostics Inc.: Company Snapshot
Table 24 : Exact Sciences Corp.: Company Snapshot
Table 25 : Freenome Holdings Inc.: Company Snapshot
Table 26 : Genecast Inc.: Company Snapshot
Table 27 : Grail Inc.: Company Snapshot
Table 28 : Guardant Health Inc.: Company Snapshot

List of Figures
Summary Figure A : Global Multi-Cancer Diagnostic Test Market, 2020-2028
Summary Figure B : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 1 : Potential Benefits of Multi-Cancer Diagnostic Tests
Figure 2 : Multi-Cancer Diagnostic Tests Market Dynamics
Figure 3 : Evidence Generation Required for Multi-Cancer Diagnostic Tests
Figure 4 : Global Multi-Cancer Diagnostic Test Market, by Test Type, 2020-2028
Figure 5 : Global Multi-Cancer Diagnostic Test Market Share, by Test Type, 2022
Figure 6 : Global Multi-Cancer Diagnostic Test Market, by End User, 2020-2028
Figure 7 : Global Multi-Cancer Diagnostic Test Market Share, by End User, 2022
Figure 8 : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 9 : Global Multi-Cancer Diagnostic Test Market Share, by Region, 2022
Figure 10 : Emerging Technologies in the Multi-Cancer Diagnosis Test Market